Cramer's Top Stock Picks: AMGN, HPY, but Avoid JCP
Amgen (AMGN - Get Report): Cramer said this drug maker delivered stellar earnings, yet saw its shares fall with the rest of the market, which is why it should be bought into weakness.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.